Gilroy RK - Search Results

1

Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center.

Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Freifeld AG, et al. Among authors: gilroy rk. Transpl Infect Dis. 2005 Sep-Dec;7(3-4):109-15. doi: 10.1111/j.1467-8365.2005.00105.x. Transpl Infect Dis. 2005. PMID: 16390398

2

Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients.

Pant C, Deshpande A, Desai M, Jani BS, Sferra TJ, Gilroy R, Olyaee M. Pant C, et al. Transpl Infect Dis. 2016 Feb;18(1):31-6. doi: 10.1111/tid.12477. Epub 2016 Jan 30. Transpl Infect Dis. 2016. PMID: 26538348

3

Microwave ablation of a large renal aspergilloma.

Waller S, Raglow Z, Lemons S, Johnson P, Eid A, Schmitt T, Smothers J, O'Neil M, Gilroy R. Waller S, et al. Transpl Infect Dis. 2014 Jun;16(3):496-500. doi: 10.1111/tid.12221. Epub 2014 May 26. Transpl Infect Dis. 2014. PMID: 24862024

4

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.

Mukherjee S, Gilroy RK, McCashland TM, Schafer DF. Mukherjee S, et al. Among authors: gilroy rk. Transplant Proc. 2003 Jun;35(4):1478-9. doi: 10.1016/s0041-1345(03)00446-9. Transplant Proc. 2003. PMID: 12826198 Clinical Trial.

5

Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.

Cauble MS, Gilroy R, Sorrell MF, Mailliard ME, Sudan DL, Anderson JC, Wisecarver JL, Balakrishnan S, Larsen JL. Cauble MS, et al. Transplantation. 2001 Apr 15;71(7):892-5. doi: 10.1097/00007890-200104150-00012. Transplantation. 2001. PMID: 11349722 Review.

6

Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.

Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW Jr, Langnas AN. Botha JF, et al. Liver Int. 2007 Aug;27(6):758-63. doi: 10.1111/j.1478-3231.2007.01490.x. Liver Int. 2007. PMID: 17617118

7

Predicting outcome of procedures to slow intestinal transit.

Thompson JS, Sudan DA, Gilroy R. Thompson JS, et al. Transplant Proc. 2006 Jul-Aug;38(6):1838-9. doi: 10.1016/j.transproceed.2006.05.007. Transplant Proc. 2006. PMID: 16908298

8

Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C.

Mailliard ME, Capadano ME, Hrnicek MJ, Gilroy RK, Gulizia JM. Mailliard ME, et al. Among authors: gilroy rk. Hepatology. 2009 Aug;50(2):361-8. doi: 10.1002/hep.22992. Hepatology. 2009. PMID: 19585621

9

A multidisciplinary approach to the treatment of intestinal failure.

Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, Horslen S, Grant W, Botha J, Langnas A. Sudan D, et al. J Gastrointest Surg. 2005 Feb;9(2):165-76; discussion 176-7. doi: 10.1016/j.gassur.2004.10.014. J Gastrointest Surg. 2005. PMID: 15694812

10

Short bowel syndrome after continence-preserving procedures.

Thompson JS, Gilroy R, Sudan D. Thompson JS, et al. J Gastrointest Surg. 2008 Jan;12(1):73-6. doi: 10.1007/s11605-007-0375-9. Epub 2007 Oct 30. J Gastrointest Surg. 2008. PMID: 17968630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters